These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32782104)

  • 1. Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.
    Thakarar K; Nenninger K; Agmas W
    Infect Dis Clin North Am; 2020 Sep; 34(3):605-620. PubMed ID: 32782104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.
    Harris RE; Richardson J; Frasso R; Anderson ED
    Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction drug policy.
    Voth EA
    Lancet Infect Dis; 2008 Sep; 8(9):528; author reply 528-9. PubMed ID: 18718436
    [No Abstract]   [Full Text] [Related]  

  • 5. 'Safer environment interventions': a qualitative synthesis of the experiences and perceptions of people who inject drugs.
    McNeil R; Small W
    Soc Sci Med; 2014 Apr; 106():151-8. PubMed ID: 24561777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young people who inject drugs in Mozambique: should we emphasize them in the National Harm Reduction Plan?
    Semá Baltazar C; Boothe M; Kellogg T
    Harm Reduct J; 2020 Mar; 17(1):20. PubMed ID: 32216809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community Perceptions of Comprehensive Harm Reduction Programs and Stigma Towards People Who Inject Drugs in Rural Virginia.
    Baker LS; Smith W; Gulley T; Tomann MM
    J Community Health; 2020 Apr; 45(2):239-244. PubMed ID: 31502098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health programmes and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: a systematic integrative review.
    Bouzanis K; Joshi S; Lokker C; Pavalagantharajah S; Qiu Y; Sidhu H; Mbuagbaw L; Qutob M; Henedi A; Levine MAH; Lennox R; Tarride JE; Kalina D; Alvarez E
    BMJ Open; 2021 Sep; 11(9):e047511. PubMed ID: 34556508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: A qualitative study.
    Dunleavy K; Hope V; Roy K; Taylor A
    Int J Drug Policy; 2019 Mar; 65():65-72. PubMed ID: 30665085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How far will they go? Assessing the travel distance of current and former drug users to access harm reduction services.
    Allen S; Ruiz M; O'Rourke A
    Harm Reduct J; 2015 Mar; 12():3. PubMed ID: 25889589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: role of community-based outreach and drop-in centers.
    Ayon S; Ndimbii J; Jeneby F; Abdulrahman T; Mlewa O; Wang B; Ragi A; Mburu G
    AIDS Care; 2018 Apr; 30(4):480-487. PubMed ID: 29067855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Controlled drug consumption rooms].
    Allilaire JF; Costentin J; Goullé JP; Hamon M; Laqueille X; Lejoyeux M; Mouren MC; Olié JP; Nordmann R; Tillement JP
    Bull Acad Natl Med; 2013 Feb; 197(2):503-5. PubMed ID: 24919375
    [No Abstract]   [Full Text] [Related]  

  • 14. Applying the Infectious Diseases Literature to People who Inject Drugs.
    Serota DP; Chueng TA; Schechter MC
    Infect Dis Clin North Am; 2020 Sep; 34(3):539-558. PubMed ID: 32782101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.
    Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J
    Int J Drug Policy; 2019 Apr; 66():87-93. PubMed ID: 30743093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary health care for people who inject drugs in low and middle income countries.
    Myers BJ
    Int J Drug Policy; 2012 Mar; 23(2):105-6. PubMed ID: 22030256
    [No Abstract]   [Full Text] [Related]  

  • 17. Access to and use of health and social services among people who inject drugs in two urban areas of Mozambique, 2014: qualitative results from a formative assessment.
    Dengo-Baloi L; Boothe M; Semá Baltazar C; Sathane I; Langa DC; Condula M; Ricardo H; Inguane C; Teodoro E; Gouveia L; Raymond HF; Horth R
    BMC Public Health; 2020 Jun; 20(1):975. PubMed ID: 32571365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-design of harm reduction materials for people who inject drugs to implement research findings.
    Hussey D; Trinder-Widdess Z; Dee C; Bagnall D; Bojangles T; Kesten JM
    Harm Reduct J; 2019 Jun; 16(1):36. PubMed ID: 31174536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Hershow RB; Gonzalez M; Costenbader E; Zule W; Golin C; Brinkley-Rubinstein L
    AIDS Educ Prev; 2019 Aug; 31(4):363-379. PubMed ID: 31361517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program.
    Ashford RD; Curtis B; Brown AM
    Harm Reduct J; 2018 Oct; 15(1):52. PubMed ID: 30348170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.